Theriva Biologics Current Deferred Revenue (Quarterly) Trends

Theriva Biologics, Inc. (TOVX)

0.1896 -0.01 (-3.22%) USD | NYAM | Dec 30, 16:00

0.1921 0.00 (0.00%) After-Hours: 16:32

View Current Deferred Revenue (Quarterly) for TOVX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Current Deferred Revenue (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Current Deferred Revenue (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Current Deferred Revenue (Quarterly) Benchmarks

Start Trial

NovaBay Pharmaceuticals, Inc.	--
Palatin Technologies, Inc.	--
Oragenics, Inc.	--
NanoViricides, Inc.	--
Actinium Pharmaceuticals, Inc.	--